Praxis Precision Medicines Inc (NASDAQ: PRAX) kicked off on Friday, up 6.48% from the previous trading day, before settling in for the closing price of $49.25. Over the past 52 weeks, PRAX has traded in a range of $26.70-$91.83.
Healthcare Sector giant saw their annual sales surged by 8.54% over the last five years. While this was happening, its average annual earnings per share was recorded -31.92%. With a float of $18.83 million, this company’s outstanding shares have now reached $21.04 million.
Praxis Precision Medicines Inc (PRAX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Praxis Precision Medicines Inc is 25.35%, while institutional ownership is 114.63%. The most recent insider transaction that took place on Nov 14 ’24, was worth 660,827. In this transaction General Counsel and Secretary of this company sold 8,239 shares at a rate of $80.20, taking the stock ownership to the 10,301 shares. Before that another transaction happened on Nov 14 ’24, when Company’s Principal Accounting Officer sold 5,188 for $81.78, making the entire transaction worth $424,318. This insider now owns 5,613 shares in total.
Praxis Precision Medicines Inc (PRAX) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -2.75 earnings per share (EPS), lower than consensus estimate (set at -1.95) by -0.8. Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -31.92% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.69% during the next five years compared to 8.54% growth over the previous five years of trading.
Praxis Precision Medicines Inc (NASDAQ: PRAX) Trading Performance Indicators
Take a look at Praxis Precision Medicines Inc’s (PRAX) current performance indicators. Last quarter, stock had a quick ratio of 6.31. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 142.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -12.29, a number that is poised to hit -3.44 in the next quarter and is forecasted to reach -12.55 in one year’s time.
Technical Analysis of Praxis Precision Medicines Inc (PRAX)
Analysing the last 5-days average volume posted by the [Praxis Precision Medicines Inc, PRAX], we can find that recorded value of 0.55 million was better than the volume posted last year of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 89.75%.
During the past 100 days, Praxis Precision Medicines Inc’s (PRAX) raw stochastic average was set at 67.14%, which indicates a significant decrease from 92.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.31 in the past 14 days, which was higher than the 2.78 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $48.05, while its 200-day Moving Average is $51.43. Now, the first resistance to watch is $54.56. This is followed by the second major resistance level at $56.69. The third major resistance level sits at $59.65. If the price goes on to break the first support level at $49.48, it is likely to go to the next support level at $46.52. Should the price break the second support level, the third support level stands at $44.39.
Praxis Precision Medicines Inc (NASDAQ: PRAX) Key Stats
The company with the Market Capitalisation of 1.10 billion has total of 21,050K Shares Outstanding. Its annual sales at the moment are 8,550 K in contrast with the sum of -182,820 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -69,300 K.
